The work done by Northwestern University Feinberg School of Medicine faculty members (and even some students) is regularly highlighted in newspapers, online media outlets and more. Below you’ll find links to articles and videos of Feinberg in the news.
–
Dr. Murad Alam, Vice-Chair of Dermatology at Northwestern University’s Feinberg School of Medicine; Professor of Dermatology, Otolaryngology, and Surgery and president of the American Academy of Dermatology (AAD), joins Lisa Dent to talk about Melanoma.
Dr. Alam shares how people can self-check for any suspicious skin markings and take preventative measures to protect themselves.
–
Dr. Sri Komanduri, Director of System Integration for the Digestive Health Institute at Northwestern Medicine, joins Wendy Snyder for this week’s health update.
Dr. Komanduri talks about the new Center for Advanced Endoscopy at Northwestern Medicine Central DuPage Hospital, how endoscopy and colonoscopy are vital for early cancer detection, and shares some new minimally invasive treatments for conditions like GERD, Barrett’s esophagus, and GI lesions.
–
Pulmonologist Dr. Ravi Kalhan, MD answers the internet’s burning questions about our lungs.
Why do we yawn and why is it contagious? How do lungs heal after a smoker quits? What chemicals actually make vaping dangerous? How does a lung transplant work? Answers to these questions and many more await on Lung Support.
–
Lipedema was first formally described at the Mayo Clinic in 1940, then named and clinically documented a decade later. Yet, despite occurring in an estimated 10% of women, lipedema is not well understood by doctors.
“There are very few physicians that are able to diagnose lipedema,” says Dr Guillermo Oliver, director of the center for vascular and developmental biology at Northwestern University.
–
Essential tremor impacts 7 million Americans who navigate their condition without a targeted treatment. Finally, that’s about to change. Research presented at the American Academy of Neurology’s annual meeting sparked excitement for the first time: a targeted therapy for essential tremor.
Movement disorders specialist Dr. Neil Shetty says the new drug is generating significant excitement because it’s designed for essential tremor.
–
The misogyny, misogynoir and vitriol that has erupted online since Megan Thee Stallion made the announcement of her breakup mirrors the backlash that many women have often experienced when opening up about their pain publicly.
In 2021, when tennis star Naomi Osaka announced that she would be withdrawing from the French Open due to her mental health, she was met with criticism and backlash. In an article that highlighted what Naomi Osaka taught Black women, Northwestern Medicine psychologist Inger Burnett-Ziegler shared, “Much of the backlash Osaka has received falls in line with the unspoken belief that women should just do what they have to do and put up with things that are harmful to them in order to pacify others, be agreeable and keep their ‘good jobs.’”
–
Dr. Sonya Bhole, a breast radiologist and associate professor at Northwestern Medicine, called the new recommendation from the American College of Physicians concerning and disappointing.
“We know the most lives saved are when we start screening mammography at age 40 and screen every year. Breast cancer incidence is on the rise. It’s on the rise in women under 50 at 1.4% per year. That’s a big number when you think about how many women there are,” Bhole said, “and so screening mammography at age 40 allows us to catch cancers at the smallest size when they’re most treatable.”
–
The American College of Physicians just released new guidance advising women to get breast cancer screenings every two years starting at 50, contradicting the American Cancer Society’s advice to get mammograms every year starting at 45.
Dr. Sonya Bhole tells Audrina Sinclair she’s disappointed in the new guidelines.
–
Kristen Venuti, an OB/GYN at Northwestern Medicine, said she has recently noticed an uptick in the number of her patients asking whether their symptoms could be a sign. “When I started my practice six years ago, I probably had one person a week bringing up perimenopause. Now several people bring it up a day.”
Understanding this hormonal milestone, experts said, can help you advocate for yourself and manage bothersome symptoms.
–
BioLineRx Ltd. and Hemispherian AS today announced that the first patient has been dosed in the first-in-human, Phase 1/2a study of GLIX1 for the treatment of recurrent and progressive glioblastoma (GBM) and other high-grade gliomas.
The patient was dosed at NYU Langone Health under the supervision of Dr. Alexandra Miller, Chief of Neuro-Oncology & Co-Director of Brain and Spine Tumor Center, Perlmutter Cancer Center. Northwestern University, led by lead investigators Dr. Roger Stupp and Dr. Ditte Primdahl, and Moffit Cancer Center, led by Dr. Patrick Grogan, will also be participating in the study.